Table 2.

SDF-1 chemokine is not required for migration of T-cell precursors into the thymus

Treatment*Presence of rhSDF-1α or α-CXCR4
Hanging dropFTOCNo. of human
cells per lobe
after 18 d of FTOC
Control No No 26 830 
Control IgG2a No Yes 25 690 
Control IgG2a Yes No 30 520 
rhSDF-1α No Yes 98 315 
rhSDF-1α Yes No 26 963 
rhSDF-1α Yes Yes 115 312 
Antihuman CXCR4 No Yes 6 213 
Antihuman CXCR4 Yes No 22 210 
Antihuman CXCR4 Yes Yes 6 004 
Treatment*Presence of rhSDF-1α or α-CXCR4
Hanging dropFTOCNo. of human
cells per lobe
after 18 d of FTOC
Control No No 26 830 
Control IgG2a No Yes 25 690 
Control IgG2a Yes No 30 520 
rhSDF-1α No Yes 98 315 
rhSDF-1α Yes No 26 963 
rhSDF-1α Yes Yes 115 312 
Antihuman CXCR4 No Yes 6 213 
Antihuman CXCR4 Yes No 22 210 
Antihuman CXCR4 Yes Yes 6 004 
*

Comparative analysis of the influence of rhSDF-1 or antihuman CXCR4 treatment on the development of human cells in chimeric human-mouse FTOC as function of time of addition of the recombinant human protein or of the blocking mAb.

Data represent the mean human cell number per lobe from 2 to 4 independent experiments.

or Create an Account

Close Modal
Close Modal